Culver City, CA, United States of America

Chihwei Chang

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Nantbio, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chihwei Chang. Retrieved from https://idiyas.com/inventor/chihwei-chang-pmd7jzmw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chihwei Chang: Innovator in Multi-Pulse Transfection Methods

Introduction

Chihwei Chang is a notable inventor based in Culver City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of transfection methods. With a total of 3 patents, his work focuses on enhancing the efficiency and viability of immune competent cells.

Latest Patents

Chihwei Chang's latest patents include innovative systems and methods for transfecting immune competent cells with RNA at high efficiency and viability. These multi-pulse transfection methods represent a breakthrough in the field, providing new avenues for research and therapeutic applications.

Career Highlights

Chihwei Chang is currently employed at Nantbio, Inc., where he continues to push the boundaries of biotechnology. His work has garnered attention for its potential impact on various medical and research fields.

Collaborations

Chihwei collaborates with talented individuals such as Marcos Sixto and Kayvan R Niazi, contributing to a dynamic and innovative work environment.

Conclusion

Chihwei Chang's contributions to multi-pulse transfection methods highlight his role as a leading inventor in biotechnology. His work not only advances scientific understanding but also opens new possibilities for medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…